These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12667668)

  • 21. Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody.
    Co MS; Scheinberg DA; Avdalovic NM; McGraw K; Vasquez M; Caron PC; Queen C
    Mol Immunol; 1993 Oct; 30(15):1361-7. PubMed ID: 8232322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.
    Thomas TC; Rollins SA; Rother RP; Giannoni MA; Hartman SL; Elliott EA; Nye SH; Matis LA; Squinto SP; Evans MJ
    Mol Immunol; 1996 Dec; 33(17-18):1389-401. PubMed ID: 9171898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a homogeneous high-throughput screening assay for biological inhibitors of human rhinovirus infection.
    Newton P; O'Shea D; Wells E; Moakes K; Dunmore R; Butler RJ; Wilkinson T; Ward A; Casson N; Strain M; Vousden K; Lowe DC; Pattison DV; Carruthers AM; Sleeman MA; Vaughan TJ; Harrison P
    J Biomol Screen; 2013 Mar; 18(3):237-46. PubMed ID: 23207740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody humanization by framework shuffling.
    Dall'Acqua WF; Damschroder MM; Zhang J; Woods RM; Widjaja L; Yu J; Wu H
    Methods; 2005 May; 36(1):43-60. PubMed ID: 15848074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.
    Iwasaki J; Smith WA; Stone SR; Thomas WR; Hales BJ
    PLoS One; 2013; 8(8):e70552. PubMed ID: 23950960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta.
    Terajima M; Yamaya M; Sekizawa K; Okinaga S; Suzuki T; Yamada N; Nakayama K; Ohrui T; Oshima T; Numazaki Y; Sasaki H
    Am J Physiol; 1997 Oct; 273(4):L749-59. PubMed ID: 9357849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humanization of a mouse neutralizing monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha).
    Nagahira K; Fukuda Y; Oyama Y; Kurihara T; Nasu T; Kawashima H; Noguchi C; Oikawa S; Nakanishi T
    J Immunol Methods; 1999 Jan; 222(1-2):83-92. PubMed ID: 10022375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.
    Ahmed M; Cheng M; Zhao Q; Goldgur Y; Cheal SM; Guo HF; Larson SM; Cheung NK
    J Biol Chem; 2015 Dec; 290(50):30018-29. PubMed ID: 26487718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
    Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
    Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural correspondences between mouse and human immunoglobulin VH genes. Application to the humanization of mouse monoclonal antibodies.
    Poul MA; Lefranc MP
    Ann N Y Acad Sci; 1995 Sep; 764():359-61. PubMed ID: 7486546
    [No Abstract]   [Full Text] [Related]  

  • 34. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.
    Apgar JR; Mader M; Agostinelli R; Benard S; Bialek P; Johnson M; Gao Y; Krebs M; Owens J; Parris K; St Andre M; Svenson K; Morris C; Tchistiakova L
    MAbs; 2016 Oct; 8(7):1302-1318. PubMed ID: 27625211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
    Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
    Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus.
    Alvi AZ; Stadnyk LL; Nagata LP; Fulton RE; Bader DE; Roehrig JT; Suresh MR
    Hybridoma; 1999 Oct; 18(5):413-21. PubMed ID: 10600028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humanization of chicken monoclonal antibody using phage-display system.
    Nishibori N; Horiuchi H; Furusawa S; Matsuda H
    Mol Immunol; 2006 Feb; 43(6):634-42. PubMed ID: 16360012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.